Eric Lin

Eric Lin is an accomplished professional with extensive experience in pharmaceutical development, currently serving as Executive Director of External R&D and Technical Services at Alvogen since May 2021. Previously, Eric held the position of Executive Director at SunGen Pharma, overseeing formulation research and development for ANDA filings. Prior roles include Senior Director of R&D at Akorn, where Eric established a GMP laboratory and led formulation development, as well as managerial positions at Novel Laboratories, Lannett Company, and Sandoz, focusing on solid dosage forms for generic therapeutics. Eric holds an M.S. in Medicinal Chemistry and Pharmaceutics from the University of the Pacific and a B.S. in Pharmacy from National Taiwan University, alongside a degree in Business Administration and Management from Kennedy-Western University.